Effects of ARBs on ambulatory blood pressure, glucose and lipid metabolism, and autonomic nerve function in hypertensive diabetic nephropathy patients

Trial Profile

Effects of ARBs on ambulatory blood pressure, glucose and lipid metabolism, and autonomic nerve function in hypertensive diabetic nephropathy patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Sep 2015

At a glance

  • Drugs Losartan (Primary) ; Telmisartan (Primary)
  • Indications Diabetic nephropathies; Hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Sep 2015 Status changed from recruiting to completed, as reported by University Hospital Medical Information Network - Japan record.
    • 22 Dec 2009 Results were presented in Koketsuatsu.
    • 03 Nov 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top